PSMB2 and central nervous system cancer: We also evaluated PSMB2 and the response to temozolomide or cisplatin which are commonly used in glioma, and the lower the expression of PSMB2 was, the higher the IC50 values of temozolomide and cisplatin (Fig. 3B,C).